Novo Nordisk A/S

NYSE: NVO · Real-Time Price · USD
52.44
1.49 (2.92%)
At close: Aug 15, 2025, 3:59 PM
56.05
6.88%
After-hours: Aug 15, 2025, 07:58 PM EDT

Novo Nordisk A/S Cash Flow Statement

Financials in DKK. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
26.5B 29.03B 28.23B 27.3B 20.05B 25.41B 21.96B 22.48B 19.43B 19.81B 13.59B 14.4B 13.32B 14.21B 10.89B 12.12B 12.12B 12.62B
Depreciation & Amortization
4.83B 3.83B 5.2B 2.15B 8.85B 2.91B 2.99B 2.52B 2.18B 1.72B 2.04B 2.04B 1.64B 1.65B 2.08B 1.35B 1.22B 1.38B
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a 2.15B n/a n/a n/a 1.54B n/a n/a n/a 1.04B n/a n/a n/a
Other Working Capital
4.75B -16.43B -981M -11.26B 9.1B -8.85B 1.93B 11.67B -4.01B -10.22B 14.38B -11.01B 4.09B 1.89B 153M 293M 2.87B -1.13B
Other Non-Cash Items
-2.61B 156M -27.47B 18.58B 30.2B 673M -34.96B 1.99B 10.71B 13.57B -12.48B 15.18B 1.44B 2.12B -18.94B 5.47B 8.14B 1.03B
Deferred Income Tax
7.3B 8B 7.33B 7.08B 5.28B 6.51B 5.66B 5.58B 4.83B 4.92B 2.72B 3.63B 3.48B 3.71B 2.22B 2.99B 2.79B 3.31B
Change in Working Capital
4.75B -16.43B -981M -11.26B 9.1B -8.85B -9.68B 11.67B -4.01B -10.22B -308M -11.01B 4.09B 1.89B -10.69B 293M 2.87B -1.13B
Operating Cash Flow
40.78B 24.59B 12.3B 43.85B 50.5B 14.31B 9.55B 40.97B 28.58B 29.81B 7.1B 24.24B 23.96B 23.59B -3.02B 21.51B 25.25B 11.26B
Capital Expenditures
-16.27B -14.59B -16.56B -12.12B -13.24B -9.01B -16.44B -10.62B -7.04B -4.8B -6.17B -4.22B -2.58B -1.78B -2.31B -1.69B -1.88B -1.5B
Cash Acquisitions
n/a n/a -81.5B 1M -668M n/a 7.03B 4.8B 1.16B 1.95B -7.08B 995M 140M 260M -18.28B 513M 175M 97M
Purchase of Investments
-582M -115M -353M -8.44B -9.87B -1.16B -948M -4.83B -5.15B -2.36B -3.12B -1.71B -3.06B -1.85B -228M -3.13B -1.41B -2.35B
Sales Maturities Of Investments
2.61B 8.03B 7.19B 35M 3.04B 14.13B 2.67B 2.21B 2.9B 515M 2.52B 970M 1.43B 1.73B 222M 179M 403M 368M
Other Investing Acitivies
-1.61B -1.16B -458M -385M -9.59B 12.43B -7.03B -4.8B -1.16B -1.95B -1.81B -995M -140M -260M -271M -513M -175M -93M
Investing Cash Flow
-14.25B -6.67B -91.22B -20.9B -20.73B 3.96B -14.72B -13.24B -9.29B -6.65B -13.85B -4.96B -4.2B -1.91B -20.6B -4.63B -2.89B -3.48B
Debt Repayment
-19.62B 15.33B 44.33B -413M 29.46B -317M -355M -261M -373M -478M -129M -330M -244M -1.71B 12.06B -175M 3.93B -349M
Common Stock Repurchased
n/a -1.39B -7.49B -2.4B -7.45B -2.84B -9.76B -6.14B -8.82B -5.2B -7.54B -4.62B -7.45B -4.48B -7.51B -3.54B -5.44B -2.96B
Dividend Paid
174M -35.27B n/a -15.58B n/a -28.56B n/a -13.43B n/a -18.34B n/a -9.61B n/a -15.69B n/a -8.02B -1M -13.49B
Other Financial Acitivies
-26.78B 26.78B n/a n/a -39.84B 5.33B n/a n/a -3.39B 3.39B n/a n/a -2.74B 2.74B n/a n/a -2.33B 2.33B
Financial Cash Flow
-46.23B 5.45B 36.84B -18.4B 16.68B -26.38B -10.12B -19.83B -12.59B -20.62B -7.67B -14.56B -10.43B -19.14B 4.55B -11.73B -3.84B -14.47B
Net Cash Flow
-20.5B 23.28B -41.36B 4.2B 46.5B -8.07B -15.49B 8.31B 6.64B 2.28B -15.26B 5.16B 9.55B 2.49B -18.77B 5.26B 18.55B -6.55B
Free Cash Flow
24.51B 10.01B -4.26B 31.73B 37.27B 5.3B -6.88B 30.34B 21.54B 25.01B 928M 20.01B 21.39B 21.81B -5.33B 19.82B 23.37B 9.76B